Burbank, CA – 
(NewMediaWire) – June 3, 2021 – Medolife
Rx, Inc. (“Medolife”), a global integrated bioceutical company
with R&D, manufacturing, and consumer product distribution, which is a
majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today
that it will hold a webcast with the investment community on Tuesday, June 8,
at 5 p.m. Eastern Daylight Time.
On the webcast, Medolife CEO
Dr. Arthur Mikaelian and Chief Financial Officer Clemente Pascarella will
discuss recent happenings with the company. To register for this webcast, please
use the below web link.
https://zoom.us/webinar/register/WN_qIvaZL5-T3C5_buGoXxpTw
If you have questions, please send an email to medolife@cmwmedia.com with
‘QNTA Question’ in the subject line by 6 p.m. Eastern Daylight Time on Monday,
June 7. Dr. Mikaelian and Mr. Pascarella will answer as many questions as time will
allow. For those unable to participate in the live webcast, an archived version
of the webcast will be available in the following days.
About
Medolife Rx
Medolife Rx, Inc. is a global biotechnology company with
operations in clinical research, manufacturing, and consumer products. Medolife
Rx was created through the merger of Medolife, a private company founded by Dr.
Arthur Mikaelian who pioneered the unlaying polarization technology that makes
the Company’s portfolio of pharmaceutical and nutraceutical products so
effective, and Quanta, Inc., a direct-to-consumer wellness product portfolio
company. The Company’s lead clinical development programs include Escozine®, a
proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which
is amplified by the Company’s polarization technology and is being researched
as a treatment of various indications, including COVID-19 and cancer. The
Company has completed preclinical safety and efficacy research on Escozine® and
is pursuing product registration and drug approval in various countries,
including the United States and throughout Latin America.
Through its subsidiary QuantRx, Medolife
manufactures and distributes consumer wellness products in high-impact consumer
areas such as pain relief, beauty, and general wellness. QuantRx products are
designed using Dr. Mikaelian’s polarization technology, which applies advances
in quantum biology to increase the potency of active ingredients. Ultimately,
Quanta’s mission is to deliver better, more effective ingredients to elevate
product efficacy, reduce waste, and facilitate healthier, more sustainable
consumption.
Beyond its own clinical and
consumer applications, the polarization technology used by Medolife and its
subsidiaries has many potential applications. From potentiating
bio-ingredients, to producing more-effective carbon-trapping plants, to
transformative anti-aging solutions, Medolife has the opportunity to upend how
commercial and pharmaceutical products are made and increase their benefits,
while decreasing their chemical concentration.
Forward-Looking Statements
Safe Harbor Statement under the
U.S. Private Securities Litigation Reform Act of 1995: This release contains
statements that are forward-looking in nature which express the beliefs and
expectations of management including statements regarding the Company’s
expected results of operations or liquidity; statements concerning projections,
predictions, expectations, estimates or forecasts as to our business, financial
and operational results and future economic performance; and statements of
management’s goals and objectives and other similar expressions concerning
matters that are not historical facts. In some cases, you can identify
forward-looking statements by terminology such as “anticipate,” “estimate,”
“plan,” “project,” “continuing,”
“ongoing,” “expect,” “we believe,” “we
intend,” “may,” “will,” “should,”
“could,” and similar expressions. Such statements are based on
current plans, estimates and expectations and involve a number of known and
unknown risks, uncertainties and other factors that could cause the Company’s
future results, performance or achievements to differ significantly from the
results, performance or achievements expressed or implied by such
forward-looking statements. These factors and additional information are
discussed in the Company’s filings with the Securities and Exchange Commission
and statements in this release should be evaluated in light of these important
factors. Although we believe that these statements are based upon reasonable
assumptions, we cannot guarantee future results. Forward-looking statements
speak only as of the date on which they are made, and the Company undertakes no
obligation to update publicly or revise any forward-looking statement, whether
as a result of new information, future developments or otherwise.
Contacts:
Tom Nelson
818-659-8052
Kyle Porter
medolife@cmwmedia.com
858-264-6600
